Virtu Financial’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,200
Closed -$37K 1755
2025
Q4
$37K Buy
19,200
+1,460
+8% +$2.91K ﹤0.01% 1336
2025
Q3
$37K Buy
+17,740
New +$40K ﹤0.01% 1182
2024
Q1
Sell
-1,172
Closed -$4K 1539
2023
Q4
$4K Buy
+1,172
New +$5.36K ﹤0.01% 1477
2023
Q2
Sell
-2,707
Closed -$34K 1611
2023
Q1
$34K Sell
2,707
-3,749
-58% -$49.8K ﹤0.01% 1160
2022
Q4
$64K Buy
6,456
+769
+14% +$8.6K 0.01% 1038
2022
Q3
$68K Buy
5,687
+1,285
+29% +$17.6K 0.01% 1145
2022
Q2
$65K Buy
+4,402
New +$66.2K 0.01% 1051
2021
Q4
Sell
-7,790
Closed -$156K 1803
2021
Q3
$156K Buy
+7,790
New +$154K 0.01% 991
2021
Q2
Sell
-12,466
Closed -$253K 1618
2021
Q1
$253K Buy
12,466
+10,547
+550% +$257K 0.02% 915
2020
Q4
$31K Buy
1,919
+313
+19% +$4.39K ﹤0.01% 1311
2020
Q3
$19K Sell
1,606
-1,837
-53% -$24.5K ﹤0.01% 926
2020
Q2
$41K Buy
+3,443
New +$42.2K ﹤0.01% 1027
2019
Q4
$41K Buy
+4,173
New +$40.6K ﹤0.01% 1228
2019
Q3
Sell
-1,586
Closed -$16K 1490
2019
Q2
$16K Buy
+1,586
New +$18.8K ﹤0.01% 1361
2019
Q1
Sell
-1,783
Closed -$15K 1478
2018
Q4
$15K Sell
1,783
-507
-22% -$5.34K ﹤0.01% 1403
2018
Q3
$27K Sell
2,290
-3,844
-63% -$51.7K ﹤0.01% 1377
2018
Q2
$86K Buy
6,134
+2,834
+86% +$37.9K 0.01% 1678
2018
Q1
$33K Buy
+3,300
New +$66.7K ﹤0.01% 1773

Other funds holding DARE

Virtu Financial's DARE Position: Q1 2026 in Review

Virtu Financial sold out of Dare Bioscience (DARE) in Q1 2026, closing a stake of 19,200 shares — an estimated $37K sold.

Virtu Financial first reported a position in DARE in Q1 2018 and held it in 18 quarters. The position peaked at $253K in Q1 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • Virtu Financial reported no remaining Dare Bioscience position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 19,200 Dare Bioscience shares in Q1 2026, an estimated $37K.
  • Virtu Financial first reported a position in Dare Bioscience in Q1 2018 and held it in 18 quarters.
  • Virtu Financial's Dare Bioscience position peaked at $253K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.